Karolin Heinze
University of British Columbia(CA)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, Reproductive System and Pregnancy, Epigenetics and DNA Methylation, Endometriosis Research and Treatment
Most-Cited Works
- → Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8 + TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas(2021)40 cited
- → Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes(2023)25 cited
- → CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients(2021)16 cited
- → Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer(2024)15 cited
- → Integrated Stability and Activity Control of the Drosophila Rbf1 Retinoblastoma Protein(2014)13 cited
- → Functional Analyses of RUNX3 and CaMKIINα in Ovarian Cancer Cell Lines Reveal Tumor-Suppressive Functions for CaMKIINα and Dichotomous Roles for RUNX3 Transcript Variants(2018)10 cited
- → The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas(2023)9 cited
- → RUNX3 Transcript Variants Have Distinct Roles in Ovarian Carcinoma and Differently Influence Platinum Sensitivity and Angiogenesis(2021)7 cited
- → Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma(2021)4 cited
- → Supplementary Figures S1-S4 from The prognostic effect of immune cell infiltration depends on molecular subtype in Endometrioid Ovarian Carcinomas(2024)